Jerusalem Pharmaceuticals Co. Ltd. (PEX:JPH)

Market Cap	47.82M
Revenue (ttm)	28.25M
Net Income (ttm)	3.57M
Shares Out	18.00M
EPS (ttm)	0.20
PE Ratio	13.40
Forward PE	n/a
Dividend	0.07 (2.67%)
Ex-Dividend Date	Apr 30, 2025

Volume	2,718
Average Volume	4,300
Open	3.760
Previous Close	n/a
Day's Range	3.750 - 3.760
52-Week Range	n/a
Beta	0.07
RSI	51.78
Earnings Date	Mar 27, 2025

About Jerusalem Pharmaceuticals

Jerusalem Pharmaceuticals Co. Ltd. develops, manufactures, and markets pharmaceutical products in Palestine, the Middle East, North Africa, and internationally. It offers range of over-the-counter, prescription pharmaceutical, and nutritional supplements products. The company produces approximately 300 pharmaceutical products in various dosage forms, such as tablets, capsules, sterile injectables, suspensions, syrups, powders, suppositories, ovules, creams, ointments, and ear and nose drops, as well as solutions. It also produces detergent, cos...

• Industry: Pharmaceutical Preparations
• Founded: 1969
• Employees: 531
• Stock Exchange: Palestine Stock Exchange
• Ticker Symbol: JPH

Financial Performance

In 2024, Jerusalem Pharmaceuticals's revenue was $39.82 million, an increase of 0.42% compared to the previous year's $39.65 million. Earnings were $5.04 million, a decrease of -27.58%.

Financial numbers in USD